E-mail this page Printer Friendly Version RSS E-mail Alerts View contacts Download Financial Tear Sheet 

2017 Press Releases

This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.

Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007
DateTitle 
11/20/17Quest Diagnostics Provides Update on Impact of Final 2018 Medicare Payment Rates for Clinical Laboratory Tests
SECAUCUS, N.J., Nov. 20, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today provided an update on the impact of the Centers for Medicare and Medicaid Services (CMS) publication of finalized 2018 Medicare reimbursement rates for clinical laboratory tests under the Clinical Lab Fee Schedule (CLFS) pursuant to the Protecting Access to Medicare Act (PAMA) announced November 17, 2017.  "We are... 
Printer Friendly Version
11/01/17Quest Diagnostics to Present New Insights in Autoimmune Disease at the 2017 American College of Rheumatology Meeting
Five Presentations Show the Clinical Value of Diagnostic Innovations for Assessing Prevalent Autoimmune Diseases, Including Rheumatoid Arthritis and Lupus Secaucus, NJ, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, announced today that it will present results of five studies at the 2017 American College of Rheumatology (ACR) Annual Meeting, November 3 – 8, 2017 in San Diego. ... 
Printer Friendly Version
10/30/17Quest Diagnostics Acquires California Laboratory Associates
Transaction Expands Access to Innovative, High-Value Diagnostic Information Services in Southern California SECAUCUS, N.J. and BURBANK, Calif., Oct. 30, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has acquired certain assets of California Laboratory Associates (CLA), a clinical lab network serving patients and providers in the Greater Los Angeles Area. CL... 
Printer Friendly Version
10/19/17Quest Diagnostics Reports Third Quarter 2017 Financial Results, Updates 2017 Financial Guidance and Reaffirms Long Term Outlook
- Third quarter revenues of $1.93 billion, up 2.4% versus 2016. - Third quarter reported diluted EPS of $1.15, down 14.2% from 2016, which included an acquisition escrow recovery gain; and $1.39 on an adjusted basis excluding amortization, up 1.5% from 2016. Excess tax benefit associated with stock-based compensation benefited diluted EPS by $0.04 in the quarter and increased $0.02 compared to 2016. - Updates outlook for full year 2017 primarily due to the financial impact of hurricanes an... 
Printer Friendly Version
10/18/17Quest Diagnostics to Acquire Cleveland HeartLab and Form Strategic Collaboration with Cleveland Clinic
- Cleveland HeartLab to be the base for Quest's first national center of excellence in cardiometabolic disorders, with a focus on services that help patients and physicians nationwide identify hidden risks of heart disease - Relationship to establish a strategic collaboration to identify and offer diagnostic services from Cleveland Clinic's innovations in inflammation and other areas of medicine SECAUCUS, N.J. and CLEVELAND, Oct. 18, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX) today... 
Printer Friendly Version
09/29/17Quest Diagnostics Completes Acquisition of the Outreach Laboratory Services of Two Hartford HealthCare Hospitals in Connecticut
Quest acquires service businesses of William W. Backus Hospital and The Hospital of Central Connecticut SECAUCUS, N.J. and HARTFORD, Conn., Sept. 29, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has acquired the outreach lab services operations of two hospitals of Hartford HealthCare (HHC), The William W. Backus Hospital and The Hospital of Central Connecticut. HHC is an integrated health care system wi... 
Printer Friendly Version
09/28/17Quest Diagnostics to Acquire Shiel Medical Laboratory from Fresenius Medical Care
Transaction to expand access to Quest's diagnostic innovations in the New York-New Jersey metropolitan area SECAUCUS, N.J., Sept. 28, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced an agreement under which Quest will acquire the Shiel Medical Laboratory business from Fresenius Medical Care, the premier healthcare company focused on delivering the highest quality care to people with renal and other ... 
Printer Friendly Version
09/28/17One in Four Individuals Combine Opioids and Benzodiazepines, a Potentially Lethal Mix, According to Journal of Addiction Medicine Study
Analysis of Quest Diagnostics prescription drug monitoring data also found that for more than half of results with concurrent use, one drug had been prescribed by a physician and one had not, suggesting potentially dangerous drug combinations without a physician's oversight SECAUCUS, N.J., Sept. 28, 2017 /PRNewswire/ -- More than 25 percent of patients monitored by lab tests for prescription drug adherence are concurrently taking both opioids and benzodiazepines, according to a new study publ... 
Printer Friendly Version
09/28/17Quest Diagnostics To Release Third Quarter 2017 Financial Results On October 19
SECAUCUS, N.J., Sept. 28, 2017 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report third quarter 2017 results on Thursday, October 19, 2017, before the market opens.  It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.  The conference call can be accessed in listen-only mode by dialing 773-756-0... 
Printer Friendly Version
09/27/17Quest Diagnostics Provides Update On Impact to Third Quarter Financial Results from Hurricanes
SECAUCUS, N.J., Sept. 27, 2017 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that for the third quarter of 2017 it expects a reduction in revenues of approximately 1.5% and a reduction in both reported earnings per share and adjusted diluted earnings per share of approximately $0.10 due to recent hurricanes.  The financial impact of these events is primarily attributable to the company's operations in ... 
Printer Friendly Version
09/22/17Quest Diagnostics Responds to Proposed PAMA 2018 Medicare Payment Rates for Clinical Laboratory Tests
SECAUCUS, N.J., Sept. 22, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, responded today to the Centers for Medicare and Medicaid Services (CMS) publication of proposed 2018 Medicare reimbursement rates for clinical laboratory tests under the Clinical Lab Fee Schedule (CLFS) pursuant to Protecting Access to Medicare Act (PAMA) announced September 22, 2017.  "We are deeply disappointed that... 
Printer Friendly Version
09/14/17Quest Diagnostics Sustainability Efforts Earn Place on DJSI World Index for Fourteenth Consecutive Year
MADISON, N.J., Sept. 14, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, was named for the thirteenth consecutive year in the North America Dow Jones Sustainability Index (DJSI) and for a fourteenth year in the World DJSI. Quest Diagnostics was one of only nine Health Care Equipment and Services companies listed on the Dow Jones Sustainability North America Index and one of only twelve compa... 
Printer Friendly Version
09/07/17Quest Diagnostics Moves to Convenient Nonfasting Cholesterol Testing with Improved Method for Assessing Heart Disease Risk and Aiding Treatment Decisions
Quest is first national diagnostic services provider to use novel LDL-cholesterol calculation that improves accuracy of heart disease screening and helps personalize treatment with lipid-lowering medications such as PCSK9 inhibitors and statins Enhances convenience as fasting prior to blood draw no longer required for reliable results SECAUCUS, N.J., Sept. 7, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced... 
Printer Friendly Version
09/06/17Quest Diagnostics To Speak At The Morgan Stanley Global Healthcare Conference
SECAUCUS, N.J., Sept. 6, 2017 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley Global Healthcare Conference in New York City.  Stephen Rusckowski, Chairman, President and CEO and Mark Guinan, Executive Vice President and CFO, will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. The presentation ... 
Printer Friendly Version
09/06/17Half of Americans Tested Misuse Their Prescription Medications, According to Quest Diagnostics Analysis
New examination of 3.4 million drug monitoring lab results shows wide evidence of dangerous drug combinations, including opioids/benzodiazepines and heroin/fentanyl MADISON, N.J., Sept. 6, 2017 /PRNewswire/ -- A majority of test results of patients taking prescription medications show signs of drug misuse, including potentially dangerous drug combinations, finds a new large-scale analysis of laboratory test results from Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic... 
Printer Friendly Version
08/18/17Quest Diagnostics Declares Quarterly Cash Dividend
MADISON, N.J., Aug. 18, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.45 per share, payable on October 18, 2017 to shareholders of record of Quest Diagnostics common stock on October 3, 2017. About Quest Diagnostics Quest Diagnostics empowers people to take action to improve health outcomes. Derived fro... 
Printer Friendly Version
07/25/17Quest Diagnostics Reports Second Quarter 2017 Financial Results, Raises 2017 Financial Outlook
- Second quarter revenues of $1.94 billion, up 1.9% on a reported basis and up 2.3% on an equivalent basis versus 2016. - Second quarter diluted EPS of $1.37, flat on a reported basis from 2016; and $1.55 on an adjusted basis excluding amortization, up 15.7% from 2016. Excess tax benefit associated with stock-based compensation benefited diluted EPS by $0.10 in the quarter and increased $0.08 compared to 2016. - Raises outlook for full year 2017 revenues, diluted EPS and cash provided by o... 
Printer Friendly Version
07/19/17Quest Diagnostics Launches QHerit™, a Pan-Ethnic Genetic Screening Panel Aligned with New Medical Guidelines
QHerit Expanded Carrier Screen helps both women and men across multiple ethnicities identify risk of passing 22 genetic diseases to their children MADISON, N.J., July 19, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the launch of QHerit™, a new genetic screening service that provides women and men with insight into their genetic risk of passing on heritable disorders to their offspring. ... 
Printer Friendly Version
07/18/17Quest Diagnostics Completes Acquisition of Med Fusion and Clear Point in Texas, Forming National Precision Oncology Center of Excellence
MADISON, N.J., July 18, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX) today announced that it has completed its previously announced acquisition of the laboratory businesses Med Fusion and Clear Point. Operating from a nearly 200,000 square foot facility in Lewisville, Texas, the two businesses form the basis for the company's first national center of excellence in precision diagnostics for oncology. In connection with the transaction, Quest is now a pr... 
Printer Friendly Version
07/06/17Quest Diagnostics To Release Second Quarter 2017 Financial Results On July 25
MADISON, N.J., July 6, 2017 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report second quarter 2017 results on Tuesday, July 25, 2017, before the market opens.  It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.  The conference call can be accessed in listen-only mode by dialing 773-799-3475, p... 
Printer Friendly Version
06/27/17Quest Diagnostics Announces Intent to Acquire Cape Cod Healthcare Outreach Laboratory Business in Massachusetts
Acquisition to Enhance Access to Innovative, High-value Diagnostic Information Services for People on Cape Cod MADISON, N.J. and HYANNIS, Mass., June 27, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has signed a nonbinding letter of intent to acquire the outreach laboratory services business of Cape Cod Healthcare (CCHC).  The acquisition is subject to review by the Massachusetts Health Policy Commiss... 
Printer Friendly Version
06/26/17Quest Diagnostics and Walmart Team Up to Expand Access to Healthcare Services
MADISON, N.J. and BENTONVILLE, Ark. , June 26, 2017-- Quest Diagnostics (NYSE: DGX) and Wal-Mart Stores, Inc. (NYSE: WMT), announced they will be working together to help improve access to care and, over time, help lower costs for basic healthcare services. The collaboration will initially launch with a select number of locations (approximately 15) in Walmart stores in Florida and Texas by the end of 2017. These co-branded sites will initially provide laboratory... 
Printer Friendly Version
06/22/17Quest Diagnostics Adds Custom Coaching, At-Home Collection to Expand Blueprint for Athletes™ Service
Fitness enthusiasts can customize biometric testing service to fit their lifestyle with redesigned packages, one-on-one coaching and goal setting as well as at-home phlebotomy and microsampling MADISON, N.J., June 22, 2017 /PRNewswire/ -- Fitness devotees and amateur and competitive athletes can now access sports biomarker testing from their home with a suite of expanded capabilities from Blueprint for Athletes, the biomarker testing service from Quest Diagnostics (NYSE: DGX) th... 
Printer Friendly Version
06/12/17Quest Diagnostics to Form Precision Oncology Center of Excellence Through Acquisition of Two Texas Laboratory Businesses to Serve Oncologists Nationwide
- Quest to acquire Lewisville, Texas-based Med Fusion and Clear Point to create a base in the southwestern United States for providing precision medicine diagnostics to aid cancer treatment and care - Transaction involves preferred provider relationships for Quest with Baylor Scott & White Health, McKesson's The US Oncology Network, Texas Oncology, and Pathologists Bio-Medical Laboratories - Once completed, the transaction will bring Quest's services to 12 hospitals in North Texas and ... 
Printer Friendly Version
06/08/17Data Diagnostics Wins 2017 MedTech Breakthrough Award
Healthcare analytics technology from Quest Diagnostics and Inovalon extends value of electronic health records to close patient gaps in real time Eighth industry award given to Data Diagnostics solution since it was formally launched in early 2016 MADISON, N.J., June 8, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX) and Inovalon (NASDAQ: INOV) announced that their point-of-care health analytics technology Data Diagnostics® won a MedTech Breakthrough Award for Best Overall... 
Printer Friendly Version
06/06/17New Study: Physicians Lack the Right Tools to Close Costly Gaps in Healthcare
Health plan executives say co-investment in HIT with providers may bridge remaining gaps and accelerate value-based care adoption MADISON, N.J., June 6, 2017 /PRNewswire/ -- 2017 QUEST DIAGNOSTICS/INOVALON STUDY FINDS: Tools still lacking to support value-based care: Fifty-three percent of health plan executives said physicians have the tools they need, but only 43 percent of physicians agreed. EHRs are not giving physicians all th... 
Printer Friendly Version
05/16/17Increases in Illicit Drugs, Including Cocaine, Drive Workforce Drug Positivity to Highest Rate in 12 Years, Quest Diagnostics Analysis Finds
Cocaine, marijuana and methamphetamine use up broadly among United States workforce across multiple specimen types and testing populations Marijuana positivity increases significantly in three years MADISON, N.J., May 16, 2017 /PRNewswire/ -- Drug use in the American workforce, fueled by illicit drugs, reached the highest positivity rate in 12 years, according to an analysis of more than ten million workforce drug test results released today by Quest Diagnostics (NYSE: DGX), the world's ... 
Printer Friendly Version
05/16/17Quest Diagnostics Declares Quarterly Cash Dividend
MADISON, N.J., May 16, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.45 per share, payable on July 24, 2017 to shareholders of record of Quest Diagnostics common stock on July 10, 2017. About Quest Diagnostics Quest Diagnostics empowers people to take action to improve health outcomes.  Derived from the w... 
Printer Friendly Version
05/12/17Quest Diagnostics To Speak At The UBS Global Healthcare Conference
MADISON, N.J., May 12, 2017 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the UBS Global Healthcare Conference in New York City.  Mark Guinan, Executive Vice President and CFO, will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. The presentation is scheduled for Tuesday, May 23, 2017 at 2:30 p.m. Eastern Time.... 
Printer Friendly Version
05/02/17Quest Diagnostics To Speak At The Deutsche Bank 42nd Annual Health Care Conference
MADISON, N.J., May 2, 2017 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Deutsche Bank 42nd Annual Health Care Conference in Boston. Mark Guinan, Executive Vice President and CFO, will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. The presentation is scheduled for Wednesday, May 3, 2017 at 9:20 a.m. Easte... 
Printer Friendly Version
05/01/17Quest Diagnostics and PeaceHealth Complete Transaction to Increase Access to Innovative, High-value Diagnostic Information Services in the Pacific Northwest
Quest completes acquisition of PeaceHealth Laboratories' outreach lab services operation Quest also begins to manage laboratories located within PeaceHealth's medical centers in three states MADISON, N.J. and VANCOUVER, Wash., May 1, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and PeaceHealth, a mission-based not-for-profit healthcare system, today announced that they have completed a previously announced two-part a... 
Printer Friendly Version
05/01/17Quest Diagnostics CIO Lidia Fonseca Wins 2017 Forbes CIO Innovation Award
Award recognizes the innovation of the QuestQuanum™ portfolio of data analytics and information technology solutions MADISON, N.J., May 1, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its senior vice president and chief information officer Lidia L. Fonseca has received a 2017 Forbes CIO Innovation Award. The award, presented during the Forbes Innovation Summit on April 24, recognizes CIOs of multibi... 
Printer Friendly Version
04/24/17Quest Diagnostics 50th Anniversary: Celebrating a Half Century of Life-Changing Results
To mark the milestone, Quest provides charitable grants of $50,000 each to the American Red Cross, the National Ovarian Cancer Coalition and Autism Speaks MADISON, N.J., April 24, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, commemorated its 50-year anniversary by awarding $150,000 in total grants to three organizations that share its goal to improve healthcare: The American Red Cross, the National Ovarian Cancer Coalit... 
Printer Friendly Version
04/24/17Data Diagnostics Wins Gold at the 30th Annual Edison Awards
Healthcare analytics technology from Quest Diagnostics and Inovalon enables patient data to be turned into actionable insights that inform quality, reimbursement and care outcomes MADISON, N.J., April 24, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX) and Inovalon (NASDAQ: INOV) announced that Data Diagnostics®, a point-of-care health analytics technology, won a gold award in the Health and Wellness—Patient Care category at the 2017 Edison Awards, which honor the best innovations and in... 
Printer Friendly Version
04/20/17Quest Diagnostics Reports First Quarter 2017 Financial Results, Raises 2017 Financial Outlook
- First quarter revenues of $1.90 billion, up 1.9% on a reported basis and up 3.0% on an equivalent basis versus 2016 - First quarter diluted EPS of $1.16 on a reported basis, up 63.4% from 2016; and $1.33 on an adjusted basis excluding amortization, up 17.7% from 2016. Excess tax benefit associated with stock-based compensation increased diluted earnings per share by $0.11 in the quarter. - Raises outlook for full year 2017 diluted EPS. Reported diluted EPS now expected to be between $4.7... 
Printer Friendly Version
04/07/17Quest Diagnostics To Release First Quarter 2017 Financial Results On April 20
MADISON, N.J., April 7, 2017 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2017 results on Thursday, April 20, 2017, before the market opens.  It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.  The conference call can be accessed in listen-only mode by dialing 888-300-0211 ... 
Printer Friendly Version
04/06/17Quest Diagnostics Presents Supplier Excellence Awards to Five Partners
MADISON, N.J., April 6, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today awarded Supplier Excellence Awards to five companies at its 2017 Supplier Forum. Supplier Excellence awards recognize world class products, systems, or services that provide consistent and reliable performance; companies that develop and implement novel solutions to move the business forward; individuals who step u... 
Printer Friendly Version
03/07/17Quest Diagnostics To Speak At The Barclays Global Healthcare Conference
MADISON, N.J., March 7, 2017 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Barclays Global Healthcare Conference in Miami. Stephen Rusckowski, Chairman, President and CEO, will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. The presentation is scheduled for Wednesday, March 15, 2017 at 8:30 a.m. Eastern Ti... 
Printer Friendly Version
03/06/17Quest Diagnostics and American Diabetes Association® to Help Identify People at Risk for Type 2 Diabetes
Quest Diagnostics will donate up to $200,000 to American Diabetes Association -- $1 for every employee biometric wellness screening it completes between March 28 and April 27 MADISON, N.J., March 6, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, including employer health and wellness screening and health improvement services, announced a unique collaboration with the American Diabetes Association aimed at helping more peo... 
Printer Friendly Version
02/21/17Quest Diagnostics Declares Quarterly Cash Dividend
MADISON, N.J., Feb.  21, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.45 per share, payable on April 19, 2017 to shareholders of record of Quest Diagnostics common stock on April 5, 2017. About Quest Diagnostics Quest Diagnostics empowers people to take action to improve health outcomes.  Derived from th... 
Printer Friendly Version
02/16/17Quest Diagnostics: Harvard Pilgrim Health Care Partners with Physicians to Close Costly Gaps in Care
Physicians to use health analytics technology Data Diagnostics® from Quest Diagnostics and Inovalon to help improve patient care and financial performance MADISON, N.J., Feb. 16, 2017 /PRNewswire/ -- Harvard Pilgrim Health Care now offers physicians Data Diagnostics®, a point-of-care health analytics technology from Quest Diagnostics (NYSE: DGX) and Inovalon (NASDAQ: INOV) that is designed to help close costly gaps in care and improve health outcomes. Ac... 
Printer Friendly Version
02/16/17Quest Diagnostics Named One of 2017 "World's Most Admired Companies" by Fortune Magazine
MADISON, N.J., Feb. 16, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been named one of the "World's Most Admired Companies" for 2017 by Fortune.  The annual survey designated Quest Diagnostics as one of only six companies in the "Health Care: Pharmacy and Other Services" industry to attain Most Admired status, and the only diagnostic information services compan... 
Printer Friendly Version
02/15/17Quest Diagnostics and PeaceHealth to Increase Access to Innovative, High-Value Laboratory Services in the Pacific Northwest
Quest to acquire PeaceHealth Laboratories' outreach lab services and assume management of labs located within PeaceHealth's medical centers in three states MADISON, N.J. and VANCOUVER, Wash., Feb. 15, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and PeaceHealth, a mission-based not-for-profit healthcare system, have formed a two-part arrangement to enhance the delivery of laboratory services to communities in Oregon, Wa... 
Printer Friendly Version
02/08/17Veracyte To Expand Patient Access To The Afirma® Gene Expression Classifier In Thyroid Cancer Diagnosis Through Agreement With Quest Diagnostics
SOUTH SAN FRANCISCO, Calif., Feb. 8, 2017 /PRNewswire/ -- Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company focused on reducing unnecessary surgeries and healthcare costs by resolving diagnostic uncertainty, will extend access to its Afirma Gene Expression Classifier (GEC) through an agreement with Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services. The agreement is intended to meet growing physician demand for innovative genomic testing ser... 
Printer Friendly Version
01/26/17Quest Diagnostics Reports Fourth Quarter And Full Year 2016 Financial Results; Provides Guidance For Full Year 2017
-- Fourth quarter revenues of $1.86 billion, up 0.7% on a reported basis and up 1.9% on an equivalent basis versus 2015 -- Fourth quarter diluted EPS of $1.09 on a reported basis, down 15.5% from 2015; fourth quarter diluted EPS of $1.31 on an adjusted basis excluding amortization, up 10.1% from 2015 -- Full year revenues of $7.52 billion, up 0.3% on a reported basis and up 2.6% on an equivalent basis versus 2015 -- Full year diluted EPS of $4.51 on a reported basis, down 7.4% from 2015... 
Printer Friendly Version
01/26/17Quest Diagnostics Partners With Montefiore Health System to Deliver High-Value, Innovative Laboratory Services
MADISON, N.J. and NEW YORK, Jan. 26, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, is working with  Montefiore Health System (MHS) to provide diagnostic laboratory services. This partnership will enhance the quality and efficiency of laboratory services at Montefiore. "We are pleased to partner with Montefiore, a premiere academic health system recognized for personalized, accountable car... 
Printer Friendly Version
01/18/17Quest Diagnostics Launches Nation's First Hepatitis B Virus Quantitative Test to Help Assess Response to Antiviral Therapy
Company expands hepatitis testing capabilities with new HBV surface antigen (sAg) quantitative testing MADISON, N.J., Jan. 18, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the launch of a new test service that helps physicians evaluate a patient's response to drug therapies used to treat infection with the hepatitis B virus (HBV). The first test of its kind available in the United States, the test is sig... 
Printer Friendly Version
01/11/17Quest Diagnostics To Release Fourth Quarter And Full Year 2016 Financial Results On January 26
MADISON, N.J., Jan. 11, 2017 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report fourth quarter and full year 2016 results on Thursday, January 26, 2017, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.  The conference call can be accessed in listen-only mode by diali... 
Printer Friendly Version
01/06/17Quest Diagnostics Achieves Perfect Score On 2017 Human Rights Campaign Corporate Equality Index
MADISON, N.J., Jan. 6, 2017 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, received a rating of 100 from the Human Rights Campaign Foundation on the 2017 Corporate Equality Index, earning the distinction of being a "Best Place to Work for LGBT Equality."  The Corporate Equality Index (CEI) is a national benchmarking survey and report on corporate policies and practices related to L... 
Printer Friendly Version
01/05/17Quest Diagnostics To Speak At The 35th Annual J.P. Morgan Healthcare Conference
MADISON, N.J., Jan. 5, 2017 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 35th Annual J.P. Morgan Healthcare Conference in San Francisco. Steve Rusckowski, Chairman, President and CEO, will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. The presentation is scheduled for Wednesday, January 11, 2017 at 5:30 ... 
Printer Friendly Version